Literature DB >> 33894293

Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets.

Xue Gong1, Qianyun Cai2, Xu Liu3, Dongmei An4, Dong Zhou5, Rong Luo6, Rong Peng7, Zhen Hong8.   

Abstract

OBJECTIVE: The aim of this study was to investigate the composition of the intestinal microbiota and its association with fecal short chain fatty acids (SCFAs) in children with drug refractory epilepsy (DRE) before and after treatment with a ketogenic diet (KD).
METHODS: Herein, we conducted a cross-sectional study of 12 children with DRE and 12 matched healthy controls to compare the changes in fecal microbiomes and SCFAs. Disease cohort also underwent analysis before and after 6 months of KD treatment.
RESULTS: A higher microbial alpha diversity and a significant increase in Actinobacteria at the phylum level and Enterococcus, Anaerostipes, Bifidobacterium, Bacteroides, and Blautia at the genus level were observed in the children with DRE. The abundance of the eight epileptic-associated genera was reversed after six months of KD treatment with decreases in Bifidobacterium, Akkermansia, Enterococcaceae and Actinomyces and increases in Subdoligranulum, Dialister, Alloprevotella (p < 0.05). In particular, we identified some taxa that were more prevalent in patients with an inadequate response to KD than in those with an adequate response. Further, a significant correlation was observed between the change in the microbiome genera after KD treatment. The SCFA content in the fecal after 6 months of KD treatment increased and was highly correlated with the gut bacteria. SIGNIFICANCES: Dysbiosis of the microbiome could be involved in the pathogenesis of DRE in children, which can be relieved by a KD to a large extent. Gut microbiota and microbial metabolism could contribute to the antiseizure effect of KD.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  16S RNA sequence; Epilepsy; Fecal microbiota; Ketogenic diets; Short chain fatty acids

Year:  2021        PMID: 33894293     DOI: 10.1016/j.micpath.2021.104899

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  Multi-omic Analysis of the Gut Microbiome in Rats with Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy.

Authors:  Maria Eduarda T Oliveira; Gustavo V B Paulino; Erivaldo D Dos Santos Júnior; Francisca A da Silva Oliveira; Vânia M M Melo; Jeferson S Ursulino; Thiago M de Aquino; Ashok K Shetty; Melissa Fontes Landell; Daniel Leite Góes Gitaí
Journal:  Mol Neurobiol       Date:  2022-08-13       Impact factor: 5.682

Review 2.  Diet and the microbiota - gut - brain-axis: a primer for clinical nutrition.

Authors:  Gabriela Ribeiro; Aimone Ferri; Gerard Clarke; John F Cryan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2022-09-14       Impact factor: 3.620

3.  Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet.

Authors:  Maria Dahlin; Stephanie S Singleton; John A David; Atin Basuchoudhary; Ronny Wickström; Raja Mazumder; Stefanie Prast-Nielsen
Journal:  EBioMedicine       Date:  2022-05-19       Impact factor: 11.205

4.  The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets.

Authors:  Ilias Attaye; Sophie van Oppenraaij; Moritz V Warmbrunn; Max Nieuwdorp
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

5.  Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children.

Authors:  Camilla Ceccarani; Ilaria Viganò; Emerenziana Ottaviano; Maria Gaia Redaelli; Marco Severgnini; Aglaia Vignoli; Elisa Borghi
Journal:  Front Cell Infect Microbiol       Date:  2021-12-03       Impact factor: 5.293

Review 6.  Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics.

Authors:  Manqiu Ding; Yue Lang; Hang Shu; Jie Shao; Li Cui
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

Review 7.  Role of Short Chain Fatty Acids in Epilepsy and Potential Benefits of Probiotics and Prebiotics: Targeting "Health" of Epileptic Patients.

Authors:  Soomin Kim; Siyeon Park; Tae Gyu Choi; Sung Soo Kim
Journal:  Nutrients       Date:  2022-07-21       Impact factor: 6.706

8.  Ketogenic Effects of Multiple Doses of a Medium Chain Triglycerides Enriched Ketogenic Formula in Healthy Men under the Ketogenic Diet: A Randomized, Double-Blinded, Placebo-Controlled Study.

Authors:  Kentaro Nakamura; Keisuke Hagihara; Naoko Nagai; Ryuichiro Egashira; Mariko Takeuchi; Mai Nakano; Hitomi Saito; Misaki Moriguchi; Satoko Tonari; Satoshi Watanabe; Akimitsu Miyake; Kinya Ashida
Journal:  Nutrients       Date:  2022-03-12       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.